Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-11-20Polish Microbiome Map
-
CLINICAL_TRIALS study record update · 2019-11-18A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Preliminary Anti-tumour Activity of Ascending Doses of Selumetinib (AZD6244 Hyd-sulfate) in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2019-11-13Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Melanoma, breAst or Lung Cancer Patients With Brain Metastases: the Phase II OPTIMAL Study
-
CLINICAL_TRIALS study record update · 2019-11-08A Phase I Study of Intravenous Recombinant Human IL-15(rhIL-15) in Adults With Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
-
CLINICAL_TRIALS study record update · 2019-11-08Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2, or IFN Based Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-10-23A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
-
CLINICAL_TRIALS study record update · 2019-10-22A Pilot Trial of HU14.18-IL2 (EMD273063) in Subjects With Completely Resectable Recurrent Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2019-10-16Study of the Modulatory Activity of an LHRH-Agonist (Leuprolide) on Melanoma Peptide Vaccines as Adjuvant Therapy in Melanoma Patients
-
CLINICAL_TRIALS study record update · 2019-10-10Phase II Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma (Neo-NivoHF10)
-
CLINICAL_TRIALS study record update · 2019-10-09Study of GSK2241658A Antigen-Specific Cancer Immunotherapeutic in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2019-10-09Phase 1/2a Study of Double-Immune Suppression Blockade By Combining a CSF1R Inhibitor (PLX3397) With An Anti-PD-1 Antibody (Pembrolizumab) To Treat Advanced Melanoma And Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-10-04Procurement of Central Nervous System and Extracranial Tumor Tissues, Cerebrospinal Fluid, and Blood From Patients With Melanoma Brain Metastases
-
CLINICAL_TRIALS study record update · 2019-10-04Phase Ib Study to Assess Safety and Tolerability of PDR001 in Combination With Panobinostat in Metastatic Melanoma and Non-small Cell Lung Cancer After Failure of Prior Anti PD1 or PD-L1 Therapy
-
CLINICAL_TRIALS study record update · 2019-10-04Multicentric Cohort of Melanoma Patients in Ile de France Area
-
CLINICAL_TRIALS study record update · 2019-10-01Improving Advanced Cancer Patient-Centered Care by Enabling Goals of Care Discussions
-
CLINICAL_TRIALS study record update · 2019-09-27A Phase I Open-Label, Non-Randomized, Dose-Escalation Study of rSIFN-co in Subjects With Advanced Solid Tumors and With an Expansion Cohort at Recommended Dose (RD) in Subjects With Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma, Hepatocellular Carcinoma or Colon Cancer
-
CLINICAL_TRIALS study record update · 2019-09-27Clinical Activity, Safety and Immunogenic Properties of Cancer Immunotherapeutic GSK2132231A in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2019-09-26A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2019-09-24Evaluation of Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
-
CLINICAL_TRIALS study record update · 2019-09-19A Phase I Dose Finding Study of Oral LTT462 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.
-
CLINICAL_TRIALS study record update · 2019-09-13A Targeted, Family-Focused Intervention for Melanoma Prevention
-
CLINICAL_TRIALS study record update · 2019-09-12ClinicalTrials.gov study NCT03007823
-
CLINICAL_TRIALS study record update · 2019-09-06A Phase 2 Study of Glembatumumab Vedotin, an Anti-gpNMB Antibody-drug Conjugate, as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2019-08-22STM-02: Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing Insulin-like Growth Factor Receptor 1 (IGF-1R)
-
CLINICAL_TRIALS study record update · 2019-08-21An Open-label, Phase II, Multicenter Study of Enhancing Pembrolizumab Responses in Melanoma Through Intratumoral pIL-12 Electroporation